Ritipenem
![]() | |
Clinical data | |
---|---|
Identifiers | |
ChemSpider | 59074 |
UNII |
D4SL77931L ![]() |
ChEMBL | CHEMBL70088 |
Chemical data | |
Formula | C10H12N2O6S |
288.3 g/mol | |
SMILES
| |
|
Ritipenem is a carbapenem class antimicrobial agent. Ritipenem is manufactured by Tanabe Seiyaku in the ritipenem acoxil prodrug form, which can be taken orally . It is not FDA approved in the United States as of 2008.
References
- Eiland E, Gatlin D (2008). Forecast of Antimicrobial Development in an Era of Increasing Bacterial Resistance. Journal of Pharmacy Practice. 21 (1): 313–18
|